Daniel Stetson

9PUBLICATIONS
87CO-AUTHORS
Liquid biopsiesCardiology (incl. cardiovascular diseases)Software quality, processes and metricsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 11, 2026
Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based Circulating Tumor DNA Assays, Version 2.0.

|Dec 26, 2025
Lexicon for Clonal Hematopoiesis in Liquid Biopsy.

Robert Tell, Ahmet Zehir, Andrew T Anfora

|Nov 06, 2025
Functional Characterization and a Real-World Clinical Laboratory Pilot of the Foundation for the National Institutes of Health Circulating Tumor DNA Quality Control Materials.

Cloud P Paweletz, Thomas D Forbes, Laura Yee

|May 01, 2024
Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer.

Jacqueline A Shaw, Karen Page, Evie Wren

|Jun 26, 2023
Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment.

Mark Roschewski, Manish R Patel, Patrick M Reagan

|Jun 06, 2022
Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.

Marla Lipsyc-Sharf, Elza C de Bruin, Katheryn Santos

Pageof 2

Frequent Collaborators

2 joint publications

James Hadfield

2 joint publications

Dana E Connors

2 joint publications

Lauren C Leiman

2 joint publications

Dorys Lopez Ramos